These results, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the strategy of focusing on ACKR3 as a unique way to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Conditions. In case you have questions https://angelinaq479pet8.weblogco.com/profile